Cargando…
Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
Breast cancer is the most prevalent type of malignancy in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherapeutic agents, while the therapeutic effect is seriously limited by the development of drug resistance. In the present study, we screened out sever...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473300/ https://www.ncbi.nlm.nih.gov/pubmed/32974144 http://dx.doi.org/10.3389/fonc.2020.01397 |
_version_ | 1783579157649686528 |
---|---|
author | Chen, Danni Bao, Chang Zhao, Feng Yu, Haogang Zhong, Guansheng Xu, Liang Yan, Senxiang |
author_facet | Chen, Danni Bao, Chang Zhao, Feng Yu, Haogang Zhong, Guansheng Xu, Liang Yan, Senxiang |
author_sort | Chen, Danni |
collection | PubMed |
description | Breast cancer is the most prevalent type of malignancy in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherapeutic agents, while the therapeutic effect is seriously limited by the development of drug resistance. In the present study, we screened out several miRNAs dysregulated in taxanes-resistant breast cancer samples and confirmed that two miRNAs (miR-335-5p and let-7c-5p) played a major role in cell proliferation, apoptosis, and chemo-resistance. In addition, the weighted gene co-expression network analysis (WGCNA) for potential target genes of miR-335-5p and let-7c-5p identified three hub genes (CXCL9, CCR7, and SOCS1) with a positive relationship to taxanes-sensitivity. Further, target relationships between miR-335-5p and CXCL9, let-7c-5p and CCR7/SOCS1 were confirmed by dual-luciferase reporter assays. Importantly, the regulatory functions of CXCL9, CCR7, and SOCS1 on proliferation and chemoresistance were validated. In conclusion, our study shed light on clinical theragnostic relationships between miR-335-5p/CXCL9, let-7c-5p/CCR7/SOCS1 axes, and taxanes-resistance in breast cancer. |
format | Online Article Text |
id | pubmed-7473300 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74733002020-09-23 Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer Chen, Danni Bao, Chang Zhao, Feng Yu, Haogang Zhong, Guansheng Xu, Liang Yan, Senxiang Front Oncol Oncology Breast cancer is the most prevalent type of malignancy in women worldwide. Taxanes (paclitaxel and docetaxel) are widely applied as first-line chemotherapeutic agents, while the therapeutic effect is seriously limited by the development of drug resistance. In the present study, we screened out several miRNAs dysregulated in taxanes-resistant breast cancer samples and confirmed that two miRNAs (miR-335-5p and let-7c-5p) played a major role in cell proliferation, apoptosis, and chemo-resistance. In addition, the weighted gene co-expression network analysis (WGCNA) for potential target genes of miR-335-5p and let-7c-5p identified three hub genes (CXCL9, CCR7, and SOCS1) with a positive relationship to taxanes-sensitivity. Further, target relationships between miR-335-5p and CXCL9, let-7c-5p and CCR7/SOCS1 were confirmed by dual-luciferase reporter assays. Importantly, the regulatory functions of CXCL9, CCR7, and SOCS1 on proliferation and chemoresistance were validated. In conclusion, our study shed light on clinical theragnostic relationships between miR-335-5p/CXCL9, let-7c-5p/CCR7/SOCS1 axes, and taxanes-resistance in breast cancer. Frontiers Media S.A. 2020-08-21 /pmc/articles/PMC7473300/ /pubmed/32974144 http://dx.doi.org/10.3389/fonc.2020.01397 Text en Copyright © 2020 Chen, Bao, Zhao, Yu, Zhong, Xu and Yan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Chen, Danni Bao, Chang Zhao, Feng Yu, Haogang Zhong, Guansheng Xu, Liang Yan, Senxiang Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer |
title | Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer |
title_full | Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer |
title_fullStr | Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer |
title_full_unstemmed | Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer |
title_short | Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer |
title_sort | exploring specific mirna-mrna axes with relationship to taxanes-resistance in breast cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473300/ https://www.ncbi.nlm.nih.gov/pubmed/32974144 http://dx.doi.org/10.3389/fonc.2020.01397 |
work_keys_str_mv | AT chendanni exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer AT baochang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer AT zhaofeng exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer AT yuhaogang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer AT zhongguansheng exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer AT xuliang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer AT yansenxiang exploringspecificmirnamrnaaxeswithrelationshiptotaxanesresistanceinbreastcancer |